Charles Schwab Investment Management Inc / PFE
Charles Schwab Investment Management Inc’s Pfizer Inc Position
Does Charles Schwab Investment Management Inc own Pfizer Inc (PFE)? Yes — 51.89M shares worth $1.5B (+0.22% of its 13F portfolio) as of Q1 2026, up from 50.54M shares the prior filed quarter.
Position Value
$1.5B
Q1 2026
Shares
51.89M
% of Portfolio
+0.22%
Quarters Held
30
currently held
Position History PFE
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 51.89M | $1.5B | +0.22% |
| Q4 2025 | 50.54M | $1.3B | +0.20% |
| Q3 2025 | 50.13M | $1.3B | +0.20% |
| Q2 2025 | 49.17M | $1.2B | +0.21% |
| Q1 2025 | 48.03M | $1.2B | +0.23% |
| Q4 2024 | 155.46M | $4.1B | +0.76% |
| Q3 2024 | 130.14M | $3.8B | +0.72% |
| Q2 2024 | 117.28M | $3.3B | +0.63% |
| Q1 2024 | 122.24M | $3.4B | +0.78% |
| Q4 2023 | 104.25M | $3.0B | +0.76% |
| Q3 2023 | 95.77M | $3.2B | +0.91% |
| Q2 2023 | 86.38M | $3.2B | +0.90% |
| Q1 2023 | 83.90M | $3.4B | +1.04% |
| Q4 2022 | 73.34M | $3.7B | +1.21% |
| Q3 2022 | 70.12M | $3.1B | +1.10% |
| Q2 2022 | 64.12M | $3.4B | +1.17% |
| Q1 2022 | 59.83M | $3.1B | +0.93% |
| Q4 2021 | 52.86M | $3.1B | +0.92% |
| Q3 2021 | 53.41M | $2.3B | +0.75% |
| Q2 2021 | 54.59M | $2.1B | +0.71% |
| Q1 2021 | 50.57M | $1.8B | +0.67% |
| Q4 2020 | 42.01M | $1.5B | +0.61% |
| Q3 2020 | 40.00M | $1.5B | +0.68% |
| Q2 2020 | 39.85M | $1.3B | +0.64% |
| Q1 2020 | 39.94M | $1.3B | +0.77% |
| Q4 2019 | 40.03M | $1.6B | +0.84% |
| Q3 2019 | 38.85M | $1.4B | +0.82% |
| Q2 2019 | 35.95M | $1.6B | +0.95% |
| Q1 2019 | 35.08M | $1.5B | +0.95% |
| Q4 2018 | 34.49M | $1.5B | +1.15% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Charles Schwab Investment Management Inc’s full portfolio or all institutional holders of PFE.